Former Senior Principal Scientist and Disease Science Director, AstraZeneca Cardiovascular & Metabolic Disease. Professor, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden. CEO of NextRx, VP Development at Stayble Therapeutics AB, member of Scientific Advisory Board, Attenua Inc.
Neuroscience